Caries Research
Original Paper
Influence of Cranberry Juice on Glucan-Mediated Processes Involved in Streptococcus mutans Biofilm DevelopmentKoo H. · Nino de Guzman P. · Schobel B.D. · Vacca Smith A.V. · Bowen W.H.Center for Oral Biology and Eastman Department of Dentistry, University of Rochester Medical Center, Rochester, N.Y., USA
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: October 08, 2004
Accepted: February 18, 2005
Published online: December 16, 2005
Issue release date: December 2005
Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 2
ISSN: 0008-6568 (Print)
eISSN: 1421-976X (Online)
For additional information: https://www.karger.com/CRE
Abstract
Cranberry juice (CJ) has biological properties that may provide health benefits. In this study, we investigated the influence of CJ (pH 5.5) on several activities in vitro associated with the development of Streptococcus mutans UA159 biofilms. The ability of CJ to influence the adherence of S. mutans to either saliva- (sHA) or glucan-coated hydroxyapatite (gsHA), and to inhibit the glucan production by purified glucosyltransferases adsorbed to sHA was determined. For the adherence assays, we used both uncoated and saliva-coated bacterial cells. Furthermore, we examined whether CJ interferes with the viability, development, polysaccharide composition and acidogenicity of S. mutans biofilms. A solution containing equivalent amounts of glucose, fructose and organic acids at pH 5.5 was used as negative control. The adherence of S. mutans (uncoated and saliva-coated) to either sHA or gsHA treated with 25% CJ (v/v) was remarkably reduced (40–85% inhibition compared to control: p < 0.05), indicating that CJ effectively blocked the bacterial adherence to binding sites in salivary pellicle and in glucans. In contrast, when the bacterial cells alone were treated with CJ they adhered to the similar untreated surfaces. Cranberry juice (25%, v/v) also inhibited the activities of surface-adsorbed GTF B and C (70–80% inhibition compared to control, p < 0.05). The effect of CJ on the viability of microorganisms in biofilms was not significant. Biofilm formation and accumulation were significantly reduced by topical applications of 25% CJ (v/v) twice daily with 1-min exposures (p < 0.05). The biomass and insoluble glucan content of the biofilms in addition to its acidogenicity were significantly reduced by cranberry treatments (p < 0.05). Our data show that cranberry juice inhibited glucan-mediated biofilm development and acid production, and holds promise as a natural product to prevent biofilm-related oral diseases.
© 2006 S. Karger AG, Basel
Related Articles:
References
- Abbot A, Hayes ML: The conditioning role of saliva in streptococcal attachment to hydroxyapatite surfaces. J Gen Microbiol 1984;130:809–816.
- Ahuja S, Kaack B, Roberts J: Loss of fimbrial adhesion with the addition of Vaccinium macrocarpon to the growth medium of P-fimbriated Escherichia coli. J Urol 1998;159:559–562.
- Banas JA, Vickerman MM: Glucan-binding proteins of the oral streptococci. Crit Rev Oral Biol Med 2003;14:89–99.
- Belli WA, Marquis RE: Adaptation of Streptococcus mutans and Enterococcus hirae to acid stress in continuous culture. Appl Environ Microbiol 1991;57:1134–1138.
- Bowen WH: Do we need to be concerned about dental caries in the coming millennium? Crit Rev Oral Biol Med 2002;13:126–131.
-
Cunningham DG, Vannozzi SA, Turk R, Roderick R, O’Shea E, Brilliant K: Cranberry phytochemicals and their health benefits; in Shahidi F, Weerasinghe DK (eds): Nutraceutical Beverages: Chemistry, Nutrition, and Health Effects. ACS Symposium Series 871. Washington, American Chemical Society, 2004, pp 35–50.
- Davis BA, Raubertas RF, Pearson SK, Bowen WH: The effects of benzoate and fluoride on dental caries in intact and desalivated rats. Caries Res 2001;35:331–337.
- Dibdin GH, Shellis RP: Physical and biochemical studies of Streptococcus mutans sediments suggest new factors linking the cariogenicity of plaque with its extracellular polysaccharide content. J Dent Res 1988;67:890–895.
- DiPersio JR, Mattingly SJ, Higgins ML, Shockman GD: Measurement of intracellular iodophilic polysaccharide in two cariogenic strains of Streptococcus mutans by cytochemical and chemical methods. Infect Immun 1974;10:597–604.
- Foo LY, Lu Y, Howell AB, Vorsa N: A-type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Nat Prod 2000;63:1225–1228.
- Harvey A: Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today 2000;5:294–300.
- Hayacibara MF, Koo H, Vacca-Smith AM, Kopec LK, Scott-Anne K, Cury JA, Bowen WH: The influence of mutanase and dextranase on the production and structure of glucans synthesized by streptococcal glucosyltransferases. Carbohydr Res 2004;339:2127–2137.
- Koo H, Hayacibara MF, Schobel BD, Cury JA, Rosalen PL, Park YK, Vacca-Smith AM, Bowen WH: Inhibition of Streptococcus mutans biofilm accumulation and polysaccharide production by apigenin and tt-farnesol. J Antimicrob Chemother 2003;52:782–789.
- Koo H, Pearson SK, Scott-Anne K, Abranches J, Cury JA, Rosalen PL, Park YK, Marquis RE, Bowen WH: Effects of apigenin and tt-farnesol on glucosyltransferase activity, biofilm viability and caries development in rats. Oral Microbiol Immunol2002a;17:337–343.
- Koo H, Rosalen PL, Cury JA, Park YK, Bowen WH: Effects of compounds found in propolis on S. mutans growth and on glucosyltransferase activity. Antimicrob Agents Chemother 2002b;46:1302–1309.
- Koo H, Vacca Smith AM, Bowen WH, Rosalen PL, Cury JA, Park YK: Effects of Apis mellifera propolis on the activities of streptococcal glucosyltransferases in solution and adsorbed ontosaliva-coated hydroxyapatite. Caries Res 2000;34:361–442.
- Loesche WJ: Role of Streptococcus mutans in human dental decay. Microbiol Rev1986;50:353–380.
- Marquis RE, Clock SA, Mota-Meira M: Fluoride and organic weak acids as modulators of microbial physiology. FEMS Microbiol Rev 2003;26:493–510.
- Marsh PD, Bradshaw DJ: Dental plaque as a biofilm. J Ind Microbiol 1995;15:169–175.
- Moore S, Stein EH: A modified ninhydrin reagent for the photometric determination of amino acids and related compounds. J Biol Chem 1954; 211:907–913.
-
Rølla G, Ciardi JE, Eggen K, Bowen WH, Afseth J: Free glucosyl- and fructosyltransferase in human saliva and adsorption of these enzymes to teeth in vivo; in Doyle RJ, Ciardi JE (eds): Glucosyltransferases, Glucans, Sucrose, and Dental Caries. Washington, IRL Press, 1983, pp 21–30.
-
SAS Institute Inc (ed): JMP® User’s Guide: Version 2 of JMP. Cary, SAS Institute, 1989.
- Schilling KM, Bowen WH: The activity of glucosyltransferases adsorbed onto saliva-coated hydroxyapatite. J Dent Res 1988;67:2–8.
- Schilling KM, Bowen WH: Glucans synthesized in situ in experimental salivary pellicle function as specific binding sites for Streptococcus mutans. Infect Immun 1992;60:284–295.
- Steinberg D, Feldman M, Ofek I, Weiss EI: Effect of a high-molecular-weight component of cranberry on constituents of dental biofilm. J Antimicrob Chemother 2004;54:86–89.
- Vvedenskaya IO, Rosen RT, Guido JE, Russell DJ, Mills KA, Vorsa N: Characterization of flavonols in cranberry (Vaccinium macrocarpon) powder. J Agric Food Chem 2004;52:188–195.
- Weiss EL, Lev-Dor R, Sharon N, Ofek I: Inhibitory effect of a high-molecular-weight constituent of cranberry on adhesion of oral bacteria. Crit Rev Food Sci Nutr 2002;42(3 suppl):285–292.
- Yamanaka A, Kimizuka R, Kato T, Okuda K: Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation. Oral Microbiol Immunol 2004;19:150–154.
- Yamashita Y, Bowen WH, Burne RA, Kuramitsu HK: Role of the Streptococcus mutansgtf genes in caries induction in the specific-pathogen-free rat model. Infect Immun 1993;61:3811–3817.
Article / Publication Details
Received: October 08, 2004
Accepted: February 18, 2005
Published online: December 16, 2005
Issue release date: December 2005
Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 2
ISSN: 0008-6568 (Print)
eISSN: 1421-976X (Online)
For additional information: https://www.karger.com/CRE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
